Atea Pharmaceuticals, Inc. Total Assets
Atea Pharmaceuticals, Inc. (AVIR) had Total Assets of $232.28 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-12
- 2026-06-30: Assets $232.28M.
- 2026-03-31: Assets $267.08M.
- 2025-12-31: Assets $315.22M.
- 2025-09-30: Assets $342.96M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $232.28M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $267.08M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $315.22M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $342.96M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $391.61M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $439.96M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $464.67M 10-K · filed 2026-03-05 |
| 2024-09-30 | $490.96M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $510.38M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $553.03M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $594.97M 10-K · filed 2025-03-06 |
| 2023-09-30 | $608.08M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $626.03M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $638.13M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $666.71M 10-K · filed 2024-02-28 |
| 2022-09-30 | $686.58M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $694.34M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $717.19M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $772.89M 10-K · filed 2023-02-28 |
| 2021-09-30 | $843.50M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $871.54M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $840.65M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $863.63M 10-K · filed 2022-02-28 |
| 2020-09-30 | $110.11M 10-Q · filed 2020-12-10 |
| 2019-12-31 | $22.07M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |